Singapore markets closed

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
282.70+1.72 (+0.61%)
As of 1:55PM EDT. Market open.
Currency in USD

Valuation measures

Market cap (intra-day) 568.28B
Enterprise value 362.06B
Trailing P/E 51.53
Forward P/E 19.44
PEG Ratio (5 yr expected) 1-0.18
Price/sales (ttm)27.28
Price/book (mrq)27.10
Enterprise value/revenue 324.80
Enterprise value/EBITDA 746.88

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3233.82%
S&P500 52-week change 335.82%
52-week high 3292.33
52-week low 354.10
50-day moving average 3226.74
200-day moving average 3156.61

Share statistics

Avg vol (3-month) 33.1M
Avg vol (10-day) 34.24M
Shares outstanding 5241.52M
Implied shares outstanding 6N/A
Float 78.56M
% held by insiders 11.18%
% held by institutions 114.79%
Shares short (29 Jun 2021) 42.23M
Short ratio (29 Jun 2021) 40.9
Short % of float (29 Jun 2021) 4N/A
Short % of shares outstanding (29 Jun 2021) 40.92%
Shares short (prior month 27 May 2021) 43.1M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin 47.81%
Operating margin (ttm)51.42%

Management effectiveness

Return on assets (ttm)32.59%
Return on equity (ttm)80.65%

Income statement

Revenue (ttm)2.5B
Revenue per share (ttm)10.40
Quarterly revenue growth (yoy)7,294.90%
Gross profit (ttm)-222.04M
EBITDA 1.32B
Net income avi to common (ttm)1.2B
Diluted EPS (ttm)5.49
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)892M
Total cash per share (mrq)3.69
Total debt (mrq)254.6M
Total debt/equity (mrq)10.10
Current ratio (mrq)2.70
Book value per share (mrq)10.43

Cash flow statement

Operating cash flow (ttm)-270.07M
Levered free cash flow (ttm)-667.78M